Latest filing published 21 Dec 2022 for AlzeCure Pharma AB, €4,510.
Filing timeline
BuySaleInsider track record
No signal scores available.
Sven Johan Bertil Edvin Sandin: trading record in brief
This profile gathers the share dealings of Sven Johan Bertil Edvin Sandin in AlzeCure Pharma AB. In total, 3 filings cover trades dated from 15 March 2022 to 21 December 2022.
No open-market purchase appears, only 1 sale. The amount is not disclosed for 1 filing.
The record was last updated on 21 December 2022 with a transaction (€4,510) in AlzeCure Pharma AB. Most trades are made public on the day they happen. Under the Market Abuse Regulation, managers have three business days to notify their trades. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from Finansinspektionen disclosures alone and does not predict where the share price will go.
Companies and markets linked to Sven Johan Bertil Edvin Sandin
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 13,334 shares@ SEK 3.7548.7% of flowBTA (betald tecknad aktie)ISIN SE0019174087FI:csv-fda6ffde54f08d3d2204
- 782,496 shares0Teckningsrätt/UniträttISIN SE0010133785FI:csv-3fd2bac6c1364bacd311
- 12,500 shares@ SEK 4.0051.3% of flowBTA (betald tecknad aktie)ISIN SE0010133785FI:csv-752111a2b71cfd77f1aa
3 of 3 declarations